Edition:
United Kingdom

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

88.63USD
20 Mar 2019
Change (% chg)

-- (--)
Prev Close
$88.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
351,310
52-wk High
$116.43
52-wk Low
$78.97

Latest Key Developments (Source: Significant Developments)

Quest Diagnostics Prices $500 Million Of Senior Notes
Thursday, 7 Mar 2019 

March 7 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS PRICES $500 MILLION OF SENIOR NOTES.QUEST DIAGNOSTICS INC - A PUBLIC OFFERING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 4.200% SENIOR NOTES DUE 2029.  Full Article

Quest Diagnostics Inc Files For Offering Of Senior Notes Due 2029
Thursday, 7 Mar 2019 

March 7 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS INC FILES FOR OFFERING OF UP TO $500 MILLION OF SENIOR NOTES DUE 2029 - SEC FILING.QUEST DIAGNOSTICS INC SAYS NOTES WILL BE ISSUED IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 IN EXCESS THEREOF.  Full Article

Quest Diagnostics-Raises Dividend By 6 Pct To An Annual Rate Of $2.12 Per Share
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Quest Diagnostics Inc ::RAISES DIVIDEND BY 6% TO AN ANNUAL RATE OF $2.12 PER SHARE.2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.57 BILLION.CASH PROVIDED BY OPERATIONS NOW EXPECTED TO APPROXIMATE $1.25 BILLION IN 2018.QUEST DIAGNOSTICS - 2018 REPORTED DILUTED EPS EXPECTED TO BE GREATER THAN $5.34, ADJUSTED DILUTED EPS EXPECTED TO BE GREATER THAN $6.30.FY2018 EARNINGS PER SHARE VIEW $6.56, REVENUE VIEW $7.62 BILLION -- REFINITIV IBES DATA.  Full Article

Quest Diagnostics to build flagship laboratory at Visionary Campus in Clifton
Wednesday, 28 Nov 2018 

Nov 28 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO BUILD FLAGSHIP LABORATORY AT VISIONARY CAMPUS IN CLIFTON, NEW JERSEY TO EMPOWER BETTER HEALTH FOR PATIENTS IN SEVEN STATES.QUEST DIAGNOSTICS - NEW LABORATORY WILL EMPLOY MORE THAN 1,100 PEOPLE.QUEST DIAGNOSTICS INC - NEW LABORATORY IS EXPECTED TO BE OPERATIONAL IN EARLY 2021.  Full Article

Quest Diagnostics To buy Laboratory Services Business Of Boyce And Bynum Pathology Laboratories
Tuesday, 27 Nov 2018 

Nov 27 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE THE LABORATORY SERVICES BUSINESS OF BOYCE AND BYNUM PATHOLOGY LABORATORIES, EXPANDING DIAGNOSTIC INNOVATION IN THE MIDWEST.QUEST DIAGNOSTICS INC - ADDITIONAL FINANCIAL TERMS OF TRANSACTION WERE NOT DISCLOSED..  Full Article

Quest Diagnostics Reports Q3 Reported Diluted EPS Of $1.53
Tuesday, 23 Oct 2018 

Oct 23 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.THIRD QUARTER REVENUES OF $1.89 BILLION, UP 1.8% FROM 2017.UPDATES OUTLOOK FOR FULL-YEAR 2018.THIRD QUARTER REPORTED DILUTED EPS OF $1.53.SEES FY 18 REPORTED DILUTED EPS NOW EXPECTED TO BE BETWEEN $5.57 AND $5.64.THIRD QUARTER ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION OF $1.68.SEES FY 2018 REPORTED REVENUES NOW EXPECTED TO BE APPROXIMATELY $7.62 BILLION.SEES FY 18 ADJUSTED DILUTED EPS EXCLUDING AMORTIZATION EXPENSE NOW EXPECTED TO BE BETWEEN $6.53 AND $6.60.  Full Article

Oxford Immunotec Sells U.S. Lab Services Business For $170 Mln To Quest Diagnostics - SEC Filing
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Quest Diagnostics Inc ::OXFORD IMMUNOTEC GLOBAL PLC - TO SELL ITS U.S. LABORATORY SERVICES BUSINESS FOR GROSS PROCEEDS OF $170 MILLION IN CASH TO QUEST DIAGNOSTICS - SEC FILING.OXFORD IMMUNOTEC GLOBAL PLC - WILL UPDATE FULL YEAR 2018 REVENUE GUIDANCE UPON CLOSING OF TRANSACTION.  Full Article

Quest To Acquire U.S. Laboratory Services Business Of Oxford Immunotec
Tuesday, 25 Sep 2018 

Sept 25 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS TO ACQUIRE U.S. LABORATORY SERVICES BUSINESS OF OXFORD IMMUNOTEC.QUEST DIAGNOSTICS INC - PARTIES EXPECT TO ENTER INTO A STRATEGIC COLLABORATION AGREEMENT TO DRIVE CONTINUED GROWTH OF T-SPOT.TB TESTING IN U.S.QUEST DIAGNOSTICS INC - INTENDS TO CONTINUE TO OFFER QUANTIFERON TB BLOOD TESTING SERVICES TO PROVIDE PHYSICIANS CHOICE IN BLOOD-BASED TB TESTING.QUEST DIAGNOSTICS - OXFORD IMMUNOTEC TO SELL T-SPOT.TB TEST KITS & RELATED ACCESSORIES TO CO UNDER TERMS OF A LONG-TERM SUPPLY AGREEMENT.  Full Article

Quest Diagnostics Acquires Reprosource
Monday, 24 Sep 2018 

Sept 24 (Reuters) - Quest Diagnostics Inc ::QUEST DIAGNOSTICS ACQUIRES REPROSOURCE, EXTENDING INTO ADVANCED FERTILITY DIAGNOSTICS.QUEST DIAGNOSTICS INC - ADDITIONAL TERMS WERE NOT DISCLOSED..  Full Article

Provant Health Enters Into Asset Purchase Agreement With Summit Health
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Quest Diagnostics Inc ::PROVANT HEALTH ENTERS INTO ASSET PURCHASE AGREEMENT WITH SUMMIT HEALTH, UNIT OF QUEST DIAGNOSTICS.HOOPER HOLMES - QUEST ASSET PURCHASE AGREEMENT IS VALUED AT $27 MILLION, TAKES FORM OF A "STALKING HORSE" BID.HOOPER HOLMES - IN CONJUNCTION WITH SALE PROCESS, CO PETITIONED FOR CHAPTER 11 BANKRUPTCY ON MONDAY, AUG. 27.HOOPER HOLMES - QUEST ASSET PURCHASE DEAL CONTAINS TRANSITION SERVICES AGREEMENT THROUGH DEC. 31.  Full Article

RPT-EXPLAINER-Why it’s so hard to diagnose Zika

CHICAGO, Oct 17 When a Zika epidemic was at its height in the Americas two years ago, diagnostics makers began working feverishly to create diagnostic tests for a virus that few in the U.S. had heard of.